Funding

SECTION I: ESTIMATION OF COSTS

 

1

Taking into account the rest of the cost evaluation please provide an overall estimation of the total costs for full deployment/production of the R & D result.
… in terms of IPR protection
National patent application 1000 EUR, international procedure of PCT is 3900 EUR.

 

 

 

…in terms of product development
It will take 6 months, the project owner will work on it for 200.000 HUF /month + insurances 60.000 HUF (1000 EUR/month), a laboratory background will work on it for 3 months 500.000 HUF/month (2000 EUR/month).
…in terms of mass production
For a small series of products the production will be done, by a subcontractor. The production cost will be, 3000 EUR/unit. The project owner will help the production, and do the necessary corrections for 200.000 HUF /month + insurances 60.000 HUF (1000 EUR/month).

 

 

… in terms of marketing
From the second year the project owner himself and an expert will work on it, 350.000 HUF /month + insurances 100.000 HUF/person (2000 EUR/month).

 

 

2

Based on the above assessment as well as the marketing information please provide the correct estimation of the price for R&D product in correlation with costs

Year 1

Year 2

Year 3

Year 4

Year 5

Fixed costs

Personnel

12000

Other running costs

9000

9000

18000

18000

18000

Marketing costs

1700

1700

1700

1700

TOTAL EXPECTED COSTS

21000

10700

19700

19700

19700

Price per Unit

3800

3800

3800 3800 3800

Type of Unit

Number of Units

1

3

6

6

6

TOTAL Expected Revenues

3800

11400

22800

22800

22800

CASH FLOW REQUIRED (REVENUES-COSTS)

-17200

700

3100

3100

3100

TOTAL CAPITAL required for five years

7200

 

 

SECTION 2: QUALITATIVE FACTORS

 

3

Dimension of identified target groups
Medical faculty of universities:  several thousand

Surgery departments of larger hospitals, clinics:  several thousand

 

4

Evaluation of financial Risks for R&D result
If the negotiations with the potential manufacturer are pointless and therefore there is no product or only a few devices can be produced, then the introduction to the market would be too slow. Competitors may come out with similar device. In this case the past and the proposed investment can be lost or recovers only partially.

 

 

 

SECTION 3: IDENTIFICATION OF FINANCING SOURCES

After evaluating all the above mentioned criteria, please tick the best financing source for the achievement of R&D result (i.e. own capitals, banking credits, venture capital, business angels, etc)

 

1. European Funding

Define relevance of the product with the following potential funding sources and comment

1.

2.

3.

4.

 

2. National Funding

1. The new Széchenyi Plan: GOP 1.3.1  if a company – not from the central region – takes over the project and fulfill the requirements of the call.

2. … KMOP 1.1.4.B (in case of the company is settled in Central Hungary).

3. …

 

3. Private funding

1. In this phase the project requires an early stage investment. It has to be offered for a seed capital fund, or a private investor (business angel) and the potential investor and the project owner has to agree on the further steps.…

 

4. Other

 

 

SECTION 3: FINAL EVALUATION

It is requested a final evaluation considering the funding opportunities you believe most suitable for the exploitation of the R&D result, considering the possibility of the creation of a spin-off, further research, in particular, a cost/benefit analysis and a financial projection for the R&D result, type of collaboration identified (i.e. Licensing Agreement, Technical Cooperation, Joint Venture, Manufacturing Agreement, Commercial Agreement with Technical Assistance, Creation of a spin-off, Joint further development)…
The result of the R&D is very promising and the intention of the project owner seems to me the most realistic solution for the exploitation of the R&D result. This is a very special product with specific market. To build up a spin-off company dealing with the entire activities from manufacturing to sell just for this unique product takes too much time and efforts and it requires sophisticated technologies and very special knowledge about the market. Much better solution is to find a manufacturer, who has some affined product (i.e.: laboratory equipment, laparoscopic devices, etc. ) and try to develop a deal with this company. To achieve a better position it would be wise to establish a small spin-off with the university for getting funds for patenting and utilizing the R&D result.

 

 

 

Decision of evaluation (Please keep only the appropriate)

  • The R&D has a high potential of exploitation. I highly recommend for further support.
Bookmark the permalink. Follow any comments here with the RSS feed for this post. Post a comment or leave a trackback: Trackback URL.

Post a Comment

You must be logged in to post a comment.

Request a proposal

Valorisation Plan Authors

Related Documents

There in no related documents

Visit the other applications of the INTERVALUE Platform: R&D Repository | IP Agreements

© 2009-2010 INTERVALUE Project